- Home
- MRNA vs TWLO Comparison
MRNA vs TWLO Comparison
Compare MRNA & TWLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- TWLO
- Stock Information
- Founded
- MRNA 2010
- TWLO 2008
- Country
- MRNA United States
- TWLO United States
- Employees
- MRNA N/A
- TWLO N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- TWLO Computer Software: Prepackaged Software
- Sector
- MRNA Health Care
- TWLO Technology
- Exchange
- MRNA Nasdaq
- TWLO Nasdaq
- Market Cap
- MRNA 10.6B
- TWLO 18.1B
- IPO Year
- MRNA 2018
- TWLO 2016
- Fundamental
- Price
- MRNA $24.68
- TWLO $105.38
- Analyst Decision
- MRNA Hold
- TWLO Buy
- Analyst Count
- MRNA 20
- TWLO 25
- Target Price
- MRNA $51.94
- TWLO $129.16
- AVG Volume (30 Days)
- MRNA 8.6M
- TWLO 2.8M
- Earning Date
- MRNA 05-01-2025
- TWLO 05-01-2025
- Dividend Yield
- MRNA N/A
- TWLO N/A
- EPS Growth
- MRNA N/A
- TWLO N/A
- EPS
- MRNA N/A
- TWLO N/A
- Revenue
- MRNA $3,177,000,000.00
- TWLO $4,583,449,000.00
- Revenue This Year
- MRNA N/A
- TWLO $10.03
- Revenue Next Year
- MRNA $22.14
- TWLO $8.13
- P/E Ratio
- MRNA N/A
- TWLO N/A
- Revenue Growth
- MRNA N/A
- TWLO 9.28
- 52 Week Low
- MRNA $23.15
- TWLO $52.51
- 52 Week High
- MRNA $170.47
- TWLO $151.95
- Technical
- Relative Strength Index (RSI)
- MRNA 42.25
- TWLO 63.20
- Support Level
- MRNA $23.70
- TWLO $92.45
- Resistance Level
- MRNA $28.52
- TWLO $105.71
- Average True Range (ATR)
- MRNA 1.34
- TWLO 3.80
- MACD
- MRNA -0.03
- TWLO 2.23
- Stochastic Oscillator
- MRNA 29.80
- TWLO 91.99
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.